Adaptyv Biosystems
Lausanne
About Adaptyv Biosystems
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $10.9M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: adaptyvbio.com
Industries & Categories
Biotechnology, Information Technology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/adaptyv-biosystems-125202 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.